Quidel Corporation 代理

详细介绍

产品咨询

世界*实验材料供应商 Quidel Corporation 上海金畔生物为其中国代理， Quidel Corporation 在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品，的服务， Quidel Corporation 就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

 Quidel Corporation 中国代理, Quidel Corporation 上海代理， Quidel Corporation 北京代理，Quidel Corporation 广东代理， Quidel Corporation 江苏代理Quidel Corporation 湖北代理,Quidel Corporation 天津,Quidel Corporation 黑龙江代理,Quidel Corporation 内蒙古代理,Quidel Corporation 吉林代理,Quidel Corporation 福建代理, Quidel Corporation 江苏代理, Quidel Corporation 浙江代理, Quidel Corporation 四川代理,

公司：www.quidel.com/

美国quidel公司是一个上市公司,本着提高人类健康和幸福的目标,在各地开拓、销售快速检测诊断试剂的企业，致力于研发产品，领域涉及妊娠、传染病、肿瘤、自身免疫性疾病和骨质疏松症

Quidel Corporation (Nasdaq: QDEL) is a California-based leading diagnostic healthcare manufacturer serving to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system.

Quidel commenced operations in 1979 and launched its first products in 1984. Since that time, Quidel has expanded its product base through internal development and acquisition with a focus on increasing its research and development efforts to accelerate the rate of new product introductions. Our core competencies and capabilities include immunoassay development, automated manufacturing, monoclonal antibody characterization and development, and molecular assay development. Our current products fall generally into these categories: (1) lateral flow, where we are market leaders in infectious disease and reproductive health; (2) direct fluorescent antibodies (DFA), with expertise in infectious disease and virology; (3) micro-titer production, with a focus on bone and complement pathway markets; (4) fluorescent immunoassay products (Sofia); and (5) molecular diagnostic products including the world’s first FDA-cleared handheld molecular device, AmpliVue. Additional molecular and Sofia tests are currently in development or in clinical trials as part of a robust product pipeline.

Whether at our headquarters in San Diego, California, at our research and manufacturing operations in Ohio, Massachusetts, or in Germany, or through our Commercial organization around the world, Quidel is delivering a continuum of diagnostic solutions from advanced lateral-flow and direct fluorescent antibody to molecular diagnostic tests that further improve the quality of healthcare.

上海金畔生物科技有限公司

世界*实验材料供应商 Quidel Corporation上海金畔生物为其中国代理， Quidel Corporation在一直是行业的*,一直为广大科研客户提供zui为的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品，的服务， Quidel Corporation就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

Quidel Corporation中国代理, Quidel Corporation上海代理， Quidel Corporation北京代理，Quidel Corporation广东代理， Quidel Corporation江苏代理Quidel Corporation湖北代理,Quidel Corporation天津,Quidel Corporation黑龙江代理,Quidel Corporation内蒙古代理,Quidel Corporation吉林代理,Quidel Corporation福建代理, Quidel Corporation江苏代理, Quidel Corporation浙江代理, Quidel Corporation四川代理,

Quidel于1979年开始运作，并于1984年推出产品。Quidel公司成立于1991年，当时Quidel和Monoclonal Antibodies合并。

Quidel目前的产品通常属于这些类别：（1）横向流动，其重点是传染病和生值健康 ; （2）直接荧光抗体（DFA），具有传染病和病毒学专业知识; （3）微量滴定法生产，重点是骨骼和补体通路市场; （4）荧光免疫测定产品（Sofia）; 和（5）分子诊断产品。

这些产品包括QuickVue，Thyretain以及新的索菲亚和AmpliVue品牌等，其重点是诊断流行性感冒，甲状腺疾病和许多其他疾病，并可以提高医院的医疗质量。

在2011年期间，美国食品和药物管理局（FDA）和欧洲合格标志公司向Quidel提供510（k）清关销售索非亚分析仪，另外还提供了510（k）的Quidel Molecular hMPV测定。

QUIDEL / EIA Kits for Assessment of Complement Activation